# Endovia Health (EDVA) — News

EDVA · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/edva/news

## Recent headlines

- [Endovia Health Sciences, - co and Lupvindol finalizing U.S. manufacturing for Cannepil](https://www.ainvest.com/news/endovia-health-sciences-lupvindol-finalizing-manufacturing-cannepil-2610) — AInvest Wire, Oct 5, 2026
- [Endovia Health Sciences - FDA further determined that minor-use status will be maintained through approval of applicable new animal drug application](https://www.ainvest.com/news/endovia-health-sciences-fda-determined-minor-status-maintained-approval-applicable-animal-drug-application-2610) — AInvest Wire, Oct 5, 2026
  The U.S. Food and Drug Administration (FDA) has confirmed that minor-use status will be maintained through the approval of applicable new animal drug applications, ensuring continued incentives for the development of treatments for uncommon diseases in major animal species and for minor species.…
- [Endovia Health Sciences, - Co and Lupvindol to meet FDA on Nov 19, 2026 for Cannepil pre-submission](https://www.ainvest.com/news/endovia-health-sciences-lupvindol-meet-fda-nov-19-2026-cannepil-pre-submission-2610) — AInvest Wire, Oct 5, 2026
- [Endovia Health Sciences, - Cannepil eligible for conditional approval pathway for canine bone cancer pain](https://www.ainvest.com/news/endovia-health-sciences-cannepil-eligible-conditional-approval-pathway-canine-bone-cancer-pain-2610) — AInvest Wire, Oct 5, 2026
  Endovia Health Sciences has announced that its product, Cannepil, has been deemed eligible for the conditional approval pathway by regulatory authorities for the treatment of canine bone cancer pain. This development marks a significant step in the company’s efforts to expand its portfolio into…
- [Endovia Health Sciences - C/M Capital Master Fund commits minimum $1 mln investment in Endovia Health Sciences - SEC filing](https://www.ainvest.com/news/endovia-health-sciences-capital-master-fund-commits-minimum-1-mln-investment-endovia-health-sciences-sec-filing-2609) — AInvest Wire, Sep 24, 2026
  Endovia Health Sciences, Inc. (NYSE American: EDVA) has announced the closing of an initial $500,000 secured convertible debt financing from C/M Capital Master Fund, LP, marking the first tranche of a previously disclosed $1 million investment commitment. The funding is intended to support the…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).